New chromone derivatives bearing thiazolidine-2,4-dione moiety as potent PTP1B inhibitors: Synthesis and biological activity evaluation

Bioorg Chem. 2024 Feb:143:106985. doi: 10.1016/j.bioorg.2023.106985. Epub 2023 Nov 23.

Abstract

A series of chromone derivatives bearing thiazolidine-2,4-dione moiety (5 ∼ 37) were synthesized and evaluated for their PTP1B inhibitory activity, interaction analysis and effects on insulin pathway in palmitic acid (PA)-induced HepG2 cells. The results showed that all derivatives presented potential PTP1B inhibitory activity with IC50 values of 1.40 ± 0.04 ∼ 16.83 ± 0.54 μM comparing to that of positive control lithocholic acid (IC50: 9.62 ± 0.14 μM). Among them, compound 9 had the strongest PTP1B inhibitory activity with the IC50 value of 1.40 ± 0.04 μM. Inhibition kinetic study revealed that compound 9 was a reversible mixed-type inhibitor against PTP1B. CD spectra results confirmed that compound 9 changed the secondary structure of PTP1B by their interaction. Molecular docking explained the detailed binding between compound 9 and PTP1B. Compound 9 also showed 19-fold of selectivity for PTP1B over TCPTP. Moreover compound 9 could recovery PA-induced insulin resistance by increasing the phosphorylation of IRSI and AKT. CETSA results showed that compound 9 significantly increased the thermal stability of PTP1B.

Keywords: Chromone; Inhibitors; Protein tyrosine phosphatase 1B; Thiazolidine-2,4-dione.

MeSH terms

  • Drug Design
  • Enzyme Inhibitors* / chemistry
  • Molecular Docking Simulation
  • Palmitic Acid / pharmacology
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1*
  • Structure-Activity Relationship
  • Thiazolidinediones*
  • Thiazolidines

Substances

  • thiazolidine-2,4-dione
  • Thiazolidines
  • Enzyme Inhibitors
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1
  • Palmitic Acid
  • Thiazolidinediones